nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ALS: neighbors matter
|
Sutherland, Stefani |
|
2005 |
10 |
2 |
p. 79- 1 p. |
artikel |
2 |
Chemical Grues and Little Willies
|
Rowe, Raymond C. |
|
2005 |
10 |
2 |
p. 91-92 2 p. |
artikel |
3 |
Chris Ashton talks about his career and the recent merger of Argenta Discovery and Etiologics
|
Carney, Steve |
|
2005 |
10 |
2 |
p. 82-85 4 p. |
artikel |
4 |
Focus on biotechnology in Australia
|
Boon, Adelaide |
|
2005 |
10 |
2 |
p. 85-88 4 p. |
artikel |
5 |
Monitor – biology
|
Davies, William |
|
2005 |
10 |
2 |
p. 157-158 2 p. |
artikel |
6 |
Monitor – chemistry
|
Guicheux, Jérôme |
|
2005 |
10 |
2 |
p. 156-157 2 p. |
artikel |
7 |
New hope for mechanism-based treatment of Parkinson's disease
|
Bradbury, Jane |
|
2005 |
10 |
2 |
p. 80-81 2 p. |
artikel |
8 |
New opportunities in Asia: a focus on India and China
|
Lawrence, Rebecca |
|
2005 |
10 |
2 |
p. 89-91 3 p. |
artikel |
9 |
Perspectives for cytokine antagonist therapy in COPD
|
de Boer, Willem I. |
|
2005 |
10 |
2 |
p. 93-106 14 p. |
artikel |
10 |
Predictive in silico modeling for hERG channel blockers
|
Aronov, Alex M. |
|
2005 |
10 |
2 |
p. 149-155 7 p. |
artikel |
11 |
Singling-out point mutations
|
Yeomans, Heather |
|
2005 |
10 |
2 |
p. 80- 1 p. |
artikel |
12 |
Target-based drug discovery: is something wrong?
|
Sams-Dodd, Frank |
|
2005 |
10 |
2 |
p. 139-147 9 p. |
artikel |
13 |
Targeting DHFR in parasitic protozoa
|
Anderson, Amy C. |
|
2005 |
10 |
2 |
p. 121-128 8 p. |
artikel |
14 |
Thalidomide as a novel therapeutic agent: new uses for an old product
|
Teo, Steve K. |
|
2005 |
10 |
2 |
p. 107-114 8 p. |
artikel |
15 |
Therapeutic scope of modulation of non-voltage-gated cation channels
|
Li, Su |
|
2005 |
10 |
2 |
p. 129-137 9 p. |
artikel |
16 |
Timely synthetic support for medicinal chemists
|
Potoski, John |
|
2005 |
10 |
2 |
p. 115-120 6 p. |
artikel |